LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 72.24 | 21.74 | 1404 | 6162 | 0.2279 | 0.6680 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.21 | 21.74 | 1537 | 6235 | 0.2465 | 0.6847 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.21 | 21.74 | 1553 | 6235 | 0.2491 | 0.6869 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.21 | 21.74 | 291 | 6235 | 0.0467 | 0.3740 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 74.21 | 21.74 | 1459 | 6235 | 0.2340 | 0.6740 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.18 | 21.74 | 1593 | 6114 | 0.2605 | 0.6952 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.18 | 21.74 | 1607 | 6114 | 0.2628 | 0.6971 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.18 | 21.74 | 302 | 6114 | 0.0494 | 0.3819 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.18 | 21.74 | 1432 | 6114 | 0.2342 | 0.6732 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.15 | 21.74 | 1632 | 6167 | 0.2646 | 0.6989 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.15 | 21.74 | 1643 | 6167 | 0.2664 | 0.7003 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.15 | 21.74 | 300 | 6167 | 0.0486 | 0.3800 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.15 | 21.74 | 1483 | 6167 | 0.2405 | 0.6791 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.12 | 21.74 | 1671 | 6211 | 0.2690 | 0.7027 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.12 | 21.74 | 1682 | 6211 | 0.2708 | 0.7041 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.12 | 21.74 | 331 | 6211 | 0.0533 | 0.3962 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.12 | 21.74 | 1509 | 6211 | 0.2429 | 0.6815 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.09 | 21.74 | 1653 | 6201 | 0.2666 | 0.7007 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.09 | 21.74 | 1667 | 6201 | 0.2688 | 0.7025 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.09 | 21.74 | 327 | 6201 | 0.0527 | 0.3943 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.09 | 21.74 | 1522 | 6201 | 0.2454 | 0.6836 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.06 | 21.74 | 1743 | 6152 | 0.2833 | 0.7131 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.06 | 21.74 | 1757 | 6152 | 0.2856 | 0.7148 | MN20160310_N01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.06 | 21.74 | 321 | 6152 | 0.0522 | 0.3918 | MN20160310_N01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.06 | 21.74 | 1502 | 6152 | 0.2441 | 0.6821 | MN20160310_N01 | N22 |